100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting praktijklessen onderste extremiteit en lumbopelvische regio $8.12   Add to cart

Summary

Samenvatting praktijklessen onderste extremiteit en lumbopelvische regio

 17 views  1 purchase
  • Course
  • Institution

Samenvatting van de praktijklessen onderste extremiteit en lumbopelvische regio van het academiejaar

Preview 4 out of 152  pages

  • June 5, 2023
  • 152
  • 2022/2023
  • Summary
avatar-seller
Academiejaar
2022 - 2023




Onderste extremiteit: praktijk
Gabriëlle Van Eekert

,Inhoudsopgave
Complexe enkelinstabiliteit – W. Waterschoot ...................................................................................................... 5
Case 1 ....................................................................................................................................................................... 5
Chronic ankle instability ........................................................................................................................................... 8
Ottawa ankle rules ................................................................................................................................................. 10
Case 1 ..................................................................................................................................................................... 11
Case 2: Bone stress injury (BSI) .............................................................................................................................. 12
Bone stress injury (BSI) ........................................................................................................................................... 13

Running injuries – W. Waterschoot...................................................................................................................... 18
Klinisch onderzoek .................................................................................................................................................. 21
Noble ...................................................................................................................................................................... 21
Renne ..................................................................................................................................................................... 21
McMurray .............................................................................................................................................................. 21
Appley .................................................................................................................................................................... 22
Thessaly .................................................................................................................................................................. 22
Varus/valgus .......................................................................................................................................................... 22
Palpatie Steinmann ................................................................................................................................................ 22
Casus ...................................................................................................................................................................... 23
Running injuries scientific evidence ........................................................................................................................ 24
Behandeldoelen & return to sport: load en load capacity ..................................................................................... 25

Pelvic girdle pain – W. Waterschoot .................................................................................................................... 29
Casus ...................................................................................................................................................................... 29
Definitie en epidemiologie ..................................................................................................................................... 30
Pijnmechanismen ................................................................................................................................................... 30
Pijn comorbiditeiten ............................................................................................................................................... 32
Classificatie ............................................................................................................................................................ 32
Klinisch redeneren - anamnese .............................................................................................................................. 35
Klinisch redeneren – klinisch onderzoek ................................................................................................................. 35
Casus ...................................................................................................................................................................... 36

Redcord 1 – D. Lambeets ..................................................................................................................................... 37
Oefentherapie – behandeling – motorische controle ............................................................................................. 39

Redcord 2 - D. Lambeets ...................................................................................................................................... 41
Prone position (Jelle) .............................................................................................................................................. 41
Prone position (Cédric) ........................................................................................................................................... 41
Sidelying position ................................................................................................................................................... 42
Contra-indicaties: ................................................................................................................................................... 43

Casuïstiek – K. Everaerts ...................................................................................................................................... 44
Casus 1 ................................................................................................................................................................... 44
Casus 2 ................................................................................................................................................................... 48

,Onderste Extremiteit &LBP – Communicatie – S. Van Dijk ................................................................................... 49
Werkpakket Communicatieve vaardigheden in de brede MSK-context ................................................................. 49
Ziektepercepties begrijpen en inventariseren ........................................................................................................ 50
Common Sense Model ...................................................................................................................................... 50
Hoe bevraag je de ziektepercepties? ................................................................................................................ 53
Communicatieve vaardigheden.............................................................................................................................. 55
Patiëntgericht communiceren ........................................................................................................................... 56
Basishoudingen in patiëntgerichte communicatie ............................................................................................ 56
Calgary-Cambridge Observatielijst .................................................................................................................... 56
Shared Decision Making ......................................................................................................................................... 57
Wat is Shared Decision Making (SDM)? ............................................................................................................ 57
Hoe SDM toepassen? ........................................................................................................................................ 58
SDM als kinesitherapeut ................................................................................................................................... 59
Artikel 1 (De Morgen) ............................................................................................................................................. 61
Artikel 2: ................................................................................................................................................................. 62

Onderzoek knie – L. Poppe................................................................................................................................... 63
Voorbereiding......................................................................................................................................................... 63
Palpaties: adductoren ............................................................................................................................................ 64
Casus NVC .............................................................................................................................................................. 64

Conservatieve behandeling van intra-articulaire pathologieën – L.Poppe............................................................ 73
Casus E.V. ............................................................................................................................................................... 73

De stijve patiënt - L. Poppe .................................................................................................................................. 85
Casus ...................................................................................................................................................................... 85
Foamrollen ............................................................................................................................................................. 85
Percussive massage treatment .............................................................................................................................. 88
Stretching ............................................................................................................................................................... 88
Foamrollen + stretchen .......................................................................................................................................... 89
Training .................................................................................................................................................................. 90

Blood Flow Restriction Training in revalidatie – L.Poppe ..................................................................................... 93
Casus: B.M. ............................................................................................................................................................. 93
Hoe kan BFR de revalidatie bevorderen? ............................................................................................................... 94
High quality research ............................................................................................................................................. 99
Veiligheid.............................................................................................................................................................. 102
Casus B.M: resultaten .......................................................................................................................................... 103
Praktijk ................................................................................................................................................................. 104
Notities: ................................................................................................................................................................ 105

Specificiteit van oefentherapie – T. Debaerdemaecker ...................................................................................... 106
Specifieke oefentherapie ...................................................................................................................................... 106
Taakspecifiek ................................................................................................................................................... 107
Mediatoren ..................................................................................................................................................... 108
Regiospecificiteit ............................................................................................................................................. 110
Specifiek weefselletsel/blessure ..................................................................................................................... 113
Coping strategieën .......................................................................................................................................... 113

, Webinar zenuwgerelateerde klachten – T. Debaerdemaecker ........................................................................... 115
Differentiaaldiagnose ........................................................................................................................................... 115

Zenuwgerelateerde letsels: onderzoek – T.Debaerdemaecker ........................................................................... 122
Casus 1: Summer .................................................................................................................................................. 122
Casus 2: Freddy .................................................................................................................................................... 125

Zenuwgerelateerde klachten: behandeling – T. Debaerdemaecker ................................................................... 131
Educatie................................................................................................................................................................ 131
Identiteit .......................................................................................................................................................... 131
Oorzaak ........................................................................................................................................................... 131
Tijdlijn .............................................................................................................................................................. 131
Prognose.......................................................................................................................................................... 131
Risicofactoren .................................................................................................................................................. 132
Controle:.......................................................................................................................................................... 132
Farmacologie ....................................................................................................................................................... 133
Oefentherapie ...................................................................................................................................................... 134
Manuele therapie ................................................................................................................................................. 136
Differentiaal diagnose .......................................................................................................................................... 137

Casuïstiek & regionaal onderzoek - I.Demeure.................................................................................................. 138
Casus .................................................................................................................................................................... 138
Onderzoek lumbopelvische regio ......................................................................................................................... 139
Actief 3D regionaal .......................................................................................................................................... 140
Passief 3D regionaal ........................................................................................................................................ 140
Onderzoek: passief 3D segmentaal ................................................................................................................. 141
Onderzoek: motorische controle .......................................................................................................................... 142
Triggerpunten .................................................................................................................................................. 143
Behandeling ......................................................................................................................................................... 145
Casus .................................................................................................................................................................... 145

Oefentherapie bij lumbopelvische klachten – I. Demeure.................................................................................. 147
Patiënt 1: acuut LRK; hockeyspeler 22 j (student) ................................................................................................ 147
Casus 2: specifieke LRK: turnster 15 jaar .............................................................................................................. 149

Herhalingsles lumbopelvische regio – I.Demeure............................................................................................... 150

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller gabrielle10. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.12. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75632 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.12  1x  sold
  • (0)
  Add to cart